Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (20 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net product sales
0
1
1
1
1
License fees
0
0
0
0
0
Total revenue
0
0
0
0
0
Cost of goods sold
0
0
1
0
0
Selling, general and administrative
7
7
5
5
5
Research and development
2
2
1
1
1
Share-based compensation
0
0
1
3
2
Other share-based expenses
0
0
0
0
0
Impairment of patents
0
0
1
0
0
Restructuring costs
0
0
0
3
0
Total operating costs and expenses
9
10
8
12
8
Loss from operations
-8
-9
-7
-12
-8
Change in Derivative liability
0
0
0
0
0
Interest expense, net
0
0
-1
0
0
Interest income
0
0
0
0
0
Gain on extinguishment of debt
0
0
0
1
0
Other income (expense), net
0
0
0
0
0
Total other income (expense)
0
0
0
1
0
Net loss
-8
-9
-8
-11
-8
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Oct 24, 2013 n/a
calculated values,
restated on Oct 28, 2014 n/a
calculated values,
restated on Oct 28, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (26 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
2
1
0
0
1
Accounts receivable, net
0
0
0
0
0
Inventories, net
1
1
0
0
0
Restricted cash
0
0
0
0
0
Prepaid expenses
0
0
0
0
0
Total current assets
3
2
0
0
2
Property, plant and equipment, net
0
0
0
0
0
Patents, net
2
2
1
1
1
Total assets
5
4
2
2
3
Liabilities and owners' equity
Accounts payable
1 677000
2 1946000
1 1134000
1 1096000
1 560000
Deferred revenue
0 0
0 66000
0 0
0 0
0 0
Note payable, current
0 0
0 0
0 368000
0 0
0 0
Restructuring liability
0 0
1 962000
0 0
0 323000
0 59000
Accrued liabilities
0 258000
0 344000
1 600000
0 401000
0 246000
Derivative liability
0 0
0 319000
0 51000
0 9000
0 4000
Total current liabilities
1 935000
4 3637000
2 2153000
2 1829000
1 869000
Note payable, less current portion
0 0
0 0
1 887000
0 0
0 0
Deferred rent
0 6000
0 3000
0 13000
0 13000
0 9000
Total liabilities
1 941000
4 3640000
3 3053000
2 1842000
1 878000
Commitments and contingencies (See Note 7)
0 0
0 0
0 0
0 0
0 0
Preferred stock, $0.01 par value: 5,000,000 shares authorized, no shares issued
0 0
0 0
0 0
0 0
0 0
Common stock, $0.01 par value: 100,000,000 shares authorized, 41,859,297 shares issued and outstanding at July 31, 2015, and 29,394,940 shares issued and outstanding at July 31, 20
0 50000
0 67000
0 126000
0 295000
0 420000
Additional paid-in capital
58 57767000
63 63251000
69 69054000
81 80943000
91 90811000
Accumulated deficit
-54 -53610000
-63 -62500000
-70 -70171000
-81 -81221000
-89 -88848000
Total stockholders' equity
4 4207000
1 818000
-1 -991000
0 17000
2 2383000
Total liabilities and stockholders' equity
5 5148000
4 4458000
2 2062000
2 1859000
3 3261000
Remarks restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (40 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net loss
-8
-9
-8
-11
-8
Share-based compensation
1
1
1
3
2
Amortization of stock issued for services
0
0
0
1
0
Stock issued under severance agreements
0
0
0
1
0
Stock issued to investors to amend subscription agreements
0
0
0
0
0
Settlement of vendor payables
0
0
0
0
0
Fair value of penalty warrants issued
0
0
0
0
0
Gain on extinguishment of debt
0
0
0
-1
0
Gain on fixed asset sale
0
0
0
0
0
Stock issued for services
0
0
0
0
0
Warrants Issued For Services
0
0
0
0
0
Depreciation and amortization
0
0
0
0
0
Impairment of patents
0
0
1
0
0
Amortization of stock issued under purchase agreement
0
0
0
0
0
Amortization of deferred financing costs
0
0
0
0
0
Change in fair value of derivative liability
0
0
0
0
0
Inventory reserve
0
0
0
0
0
Troubled debt restructuring loss
0
0
0
0
0
Amortization of deferred financing costs
0
0
0
0
0
Amortization of debt discount
0
0
0
0
0
Accounts receivable
0
0
0
0
0
Inventories
0
0
0
0
0
Restricted cash
0
0
0
0
0
Accounts payable and accrued liabilities
0
1
1
0
-1
Deferred revenue
0
0
0
0
0
Deferred rent
0
0
0
0
0
Net cash used in operating activities
-6
-6
-4
-6
-6
Investment in patents
0
0
0
0
0
Proceeds from on sale of fixed assets
0
0
0
0
0
Purchases of property, plant and equipment
0
0
0
0
0
Deferred financing costs
0
0
0
0
0
Net proceeds from exercise of stock options and warrants
1
0
0
0
0
Net cash used in investing activities
0
0
0
0
0
Net proceeds from the sale of common stock
5
4
5
7
7
Net proceeds from the exercise of warrants
0
1
0
0
0
Payment of Bridge Loan
0
0
-1
0
0
Payment on note payable
0
0
0
-1
0
Net cash provided by financing activities
6
5
3
6
7
Net increase in cash and cash equivalents
0
-1
-1
0
1
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Oct 28, 2014 n/a
calculated values,
restated on Oct 28, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo